Your practice here will be genuinely end-to-end. On any given week, that might mean providing IP counsel for an asset in early discovery, managing prosecution strategy across multiple patent portfolios in global markets, leading an FTO analysis for a BD transaction, or advising commercial teams on exclusivity positions before a product launch.
Own patent preparation and prosecution across global markets, with a focus on building meaningful exclusivity for BridgeBio’s pharmaceutical assets from discovery through life-cycle management.
Lead freedom-to-operate assessments relevant to drug development, commercialization, and strategic transactions, identifying and mitigating risk with clear, actionable guidance.
Provide IP counsel across the full asset lifecycle, including on exclusivity strategy and operating in competitive environments.
Serve as a trusted IP advisor to cross-functional teams including R&D, BD, Regulatory, and Commercial, delivering timely and business-relevant counsel that advances BridgeBio’s mission.
Support U.S. and ex-U.S. adversarial proceedings as they arise, including inter partes reviews, post-grant reviews, EP oppositions, and patent litigation.